These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
328 related items for PubMed ID: 26379151
1. Morphologic Features of ALK-negative Anaplastic Large Cell Lymphomas With DUSP22 Rearrangements. King RL, Dao LN, McPhail ED, Jaffe ES, Said J, Swerdlow SH, Sattler CA, Ketterling RP, Sidhu JS, Hsi ED, Karikehalli S, Jiang L, Gibson SE, Ondrejka SL, Nicolae A, Macon WR, Dasari S, Parrilla Castellar E, Feldman AL. Am J Surg Pathol; 2016 Jan; 40(1):36-43. PubMed ID: 26379151 [Abstract] [Full Text] [Related]
2. ALK-negative anaplastic large cell lymphoma is a genetically heterogeneous disease with widely disparate clinical outcomes. Parrilla Castellar ER, Jaffe ES, Said JW, Swerdlow SH, Ketterling RP, Knudson RA, Sidhu JS, Hsi ED, Karikehalli S, Jiang L, Vasmatzis G, Gibson SE, Ondrejka S, Nicolae A, Grogg KL, Allmer C, Ristow KM, Wilson WH, Macon WR, Law ME, Cerhan JR, Habermann TM, Ansell SM, Dogan A, Maurer MJ, Feldman AL. Blood; 2014 Aug 28; 124(9):1473-80. PubMed ID: 24894770 [Abstract] [Full Text] [Related]
3. Molecular profiling reveals immunogenic cues in anaplastic large cell lymphomas with DUSP22 rearrangements. Luchtel RA, Dasari S, Oishi N, Pedersen MB, Hu G, Rech KL, Ketterling RP, Sidhu J, Wang X, Katoh R, Dogan A, Kip NS, Cunningham JM, Sun Z, Baheti S, Porcher JC, Said JW, Jiang L, Hamilton-Dutoit SJ, Møller MB, Nørgaard P, Bennani NN, Chng WJ, Huang G, Link BK, Facchetti F, Cerhan JR, d'Amore F, Ansell SM, Feldman AL. Blood; 2018 Sep 27; 132(13):1386-1398. PubMed ID: 30093402 [Abstract] [Full Text] [Related]
4. Striking Association of Lymphoid Enhancing Factor (LEF1) Overexpression and DUSP22 Rearrangements in Anaplastic Large Cell Lymphoma. Ravindran A, Feldman AL, Ketterling RP, Dasari S, Rech KL, McPhail ED, Kurtin PJ, Shi M. Am J Surg Pathol; 2021 Apr 01; 45(4):550-557. PubMed ID: 33165091 [Abstract] [Full Text] [Related]
5. Expression of the chemokine receptor gene, CCR8, is associated With DUSP22 rearrangements in anaplastic large cell lymphoma. Xing X, Flotte TJ, Law ME, Blahnik AJ, Chng WJ, Huang G, Knudson RA, Ketterling RP, Porcher JC, Ansell SM, Sidhu J, Dogan A, Feldman AL. Appl Immunohistochem Mol Morphol; 2015 Sep 01; 23(8):580-9. PubMed ID: 25390351 [Abstract] [Full Text] [Related]
9. Expression of p63 protein in anaplastic large cell lymphoma: implications for genetic subtyping. Wang X, Boddicker RL, Dasari S, Sidhu JS, Kadin ME, Macon WR, Ansell SM, Ketterling RP, Rech KL, Feldman AL. Hum Pathol; 2017 Jun 01; 64():19-27. PubMed ID: 28153507 [Abstract] [Full Text] [Related]
10. DUSP22-rearranged primary cutaneous CD30-positive T-cell lymphoproliferative disorders and adult T-cell leukemia/lymphoma frequently share the LEF1+/TIA1- immunophenotype. Chen BJ, Hsieh SM, Hsieh TH, Jhuang JY, Kao YC. Hum Pathol; 2024 Aug 01; 150():58-66. PubMed ID: 38971328 [Abstract] [Full Text] [Related]
11. Immunohistochemical Approach to Genetic Subtyping of Anaplastic Large Cell Lymphoma. Feldman AL, Oishi N, Ketterling RP, Ansell SM, Shi M, Dasari S. Am J Surg Pathol; 2022 Nov 01; 46(11):1490-1499. PubMed ID: 35941721 [Abstract] [Full Text] [Related]
12. JAK/STAT3 Signaling Activation Related to Distinct Clinicopathologic Features in Systemic ALK - Anaplastic Large Cell Lymphomas : New Insights into Their Heterogeneity. Wang JC, Zhong LH, Lin WQ, Zhang WF, Xi YF, Liu YP, Zhu Q, Liu W, Zhu WF, Chen YP, Chen G. Am J Surg Pathol; 2023 Jan 01; 47(1):55-64. PubMed ID: 36315833 [Abstract] [Full Text] [Related]
14. [Detection of chromosomal translocations of DUSP22 and TP63 in ALK-negative anaplastic large cell lymphoma by fluorescence in situ hybridization and related clinical relevance]. Wang C, Chen X, Chen XY, He YH. Zhonghua Bing Li Xue Za Zhi; 2019 Oct 08; 48(10):791-795. PubMed ID: 31594044 [Abstract] [Full Text] [Related]
15. ALCL by any other name: the many facets of anaplastic large cell lymphoma. Irshaid L, Xu ML. Pathology; 2020 Jan 08; 52(1):100-110. PubMed ID: 31706671 [Abstract] [Full Text] [Related]
16. DUSP22 rearrangement is associated with a distinctive immunophenotype but not outcome in patients with systemic ALK-negative anaplastic large cell lymphoma. Qiu L, Tang G, Li S, Vega F, Lin P, Wang SA, Wang W, Iyer SP, Malpica L, Miranda RN, Konoplev S, Tang Z, Fang H, Medeiros LJ, Xu J. Haematologica; 2023 Jun 01; 108(6):1604-1615. PubMed ID: 36453104 [Abstract] [Full Text] [Related]
17. Discovery of recurrent t(6;7)(p25.3;q32.3) translocations in ALK-negative anaplastic large cell lymphomas by massively parallel genomic sequencing. Feldman AL, Dogan A, Smith DI, Law ME, Ansell SM, Johnson SH, Porcher JC, Ozsan N, Wieben ED, Eckloff BW, Vasmatzis G. Blood; 2011 Jan 20; 117(3):915-9. PubMed ID: 21030553 [Abstract] [Full Text] [Related]
18. Intralymphatic cutaneous anaplastic large cell lymphoma/lymphomatoid papulosis: expanding the spectrum of CD30-positive lymphoproliferative disorders. Samols MA, Su A, Ra S, Cappel MA, Louissant A, Knudson RA, Ketterling RP, Said J, Binder S, Harris NL, Feldman AL, Kim J, Kim YH, Gratzinger D. Am J Surg Pathol; 2014 Sep 20; 38(9):1203-11. PubMed ID: 24805854 [Abstract] [Full Text] [Related]
19. Progress in the identification of subgroups in ALK-negative anaplastic large-cell lymphoma. Boddicker RL, Feldman AL. Biomark Med; 2015 Sep 20; 9(8):719-22. PubMed ID: 26223379 [No Abstract] [Full Text] [Related]
20. Cutaneous presentation of enteropathy-associated T-cell lymphoma masquerading as a DUSP22-rearranged CD30+ lymphoproliferation. Bisig B, Cairoli A, Gaide O, Somja J, Bregnard C, Gaulard P, Xerri L, Lefort K, Missiaglia E, Gilliet M, Hohl D, Guenova E, de Leval L. Virchows Arch; 2022 Oct 20; 481(4):653-657. PubMed ID: 35366115 [Abstract] [Full Text] [Related] Page: [Next] [New Search]